Medicinal plants of the genus Hypericum L. have been widely used in both traditional and contemporary medicine for many years. According to the literature antimicrobial, anti-urease, anti-crystallization activities and toxicity studies of petroleum ether, chloroform and methanol extracts from H.scabrum and H. triquetrifolium species have not reported yet. The purpose of this study is to investigate the biological activities of the extracts using in vitro and in silico techniques and to evaluate their chemical composition. The pharmacokinetic characteristics of the substances are also to be ascertained. The results showed that the methanol extracts were rich in total phenolic content. The extracts showed potent anti-urease, anti-crystallization and antimicrobial activity. Methanol extracts didn’t show toxicity in the normal cell line (L-929). Also, this work used HPLC-DAD to quantitatively assess the amounts of isorhamnetin, rutin, and chlorogenic acid in methanol extracts from both plants. Docking studies were performed with anticholinesterase, urease, cytochrome P450, lipoxygenase, myeloperoxidase, xanthine oxidase and NADPH enzymes and phenolics by using docking program. With a binding affinity of -10.3 kcal/mol, chlorogenic acid docks to the xanthine oxidase enzyme's active site. Rutin binds to the myeloperoxidase enzyme's active site with a binding affinity of -9,9 kcal/mol. With a binding affinity of -9,4 kcal/mol, the isorhamnetin docks to the active site of the myeloperoxidase enzyme. The drug likeness properties of the phenolics were predicted by SwissADME. According to Lipinski's five guidelines, it was found that the compounds didn’nt exhibit mutagenic and hepatotoxic effects. The findings indicate that methanol extracts exhibit biological activities.
28 October 2024 in Journal of Drug Delivery Science and Technology
Background: Gene therapeutics are being developed to treat metastatic breast tumors, which are mostly resistant to conventional therapies. Targeting platelet-derived growth factor-D (PDGF-D) is a viable approach because it is known to play roles in angiogenesis and tumor growth. The success of gene therapy is largely dependent on delivery vectors, but both viral and nonviral delivery vectors have their own disadvantages. Evolving hybrid vectors are being used to overcome those disadvantages. Objectives: In this study, we aimed to prepare a recombinant adenovirus type-5 (Ad5)/chitosan hybrid vector to deliver shPDGF-D in a breast cancer cell line by the noncovalent coating of the Ad5 surface with chitosan, a natural polymer. Methods: The Ad5/chitosan hybrid vector was prepared by the noncovalent coating of the Ad5 surface with different molecular weights (low and high) and different amounts of chitosan (12.5, 25, and 50 µg) and the effect of silencing PDGF-D was investigated in the MDA-MB-231 cell line. Results: In vitro characterization studies showed that the noncovalent chitosan coating increased the size of the Ad5 particle and changed the surface charge from -16.53 mV to slightly neutral. In vitro cell culture studies also showed that the addition of chitosan with both low (73.61%) and high (65.86%) molecular weight increased the PDGF-D silencing efficiency of the Ad5 vector (42.44%) at 48 hours. While low-molecular-weight chitosan had faster effects, high-molecular-weight chitosan provided a more sustained effect in PDGF-D silencing. Conclusion: The results indicate that noncovalent chitosan modification may improve the therapeutic effects of the Ad5 vector, offering potential for further in vitro and in vivo experiments.